Position in STTK
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$3,610,992
+$2,800,420 QoQ
Shares Held
520,316
+312.7% QoQ
Ownership
0.518%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#25
of 100 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 98%
Shared 2%
None 0%
Common Shares in STTK Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026NORTHERN TRUST CORP holds $7,872,952,300 across 424 Biotechnology names. STTK ranks #191 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,486,478 | $1,235,108,212 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
916,467 | $571,453,829 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
886,900 | $266,983,504 | |
| 4 | RPRX |
Royalty Pharma plc
|
4,718,859 | $264,586,419 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
1,117,110 | $209,212,357 | |
| 6 | MRNA |
Moderna, Inc.
|
2,985,329 | $209,062,587 | |
| 7 | INCY |
Incyte Corp
|
1,761,966 | $199,736,460 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,647,345 | $140,337,319 |
All Filings in STTK
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,610,992 | 520,316 | Shares | Other | 2026-08-13 | |
| 2026-03-31 | $810,572 | 126,061 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $530,873 | 145,445 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $218,139 | 91,272 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $87,897 | 110,983 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $329,783 | 347,142 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $427,873 | 353,616 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $1,129,873 | 323,746 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $415,115 | 107,543 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $858,212 | 95,997 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $584,823 | 82,023 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $103,459 | 68,066 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $219,079 | 70,218 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $193,127 | 65,690 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $142,661 | 62,027 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $167,772 | 62,138 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $228,163 | 56,198 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $1,068,701 | 250,869 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $2,300,865 | 270,372 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $5,380,788 | 264,023 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $7,317,219 | 252,405 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $4,172,576 | 142,701 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $7,865,692 | 150,080 | Shares | Defined | 2021-02-11 | |
| No filing history on record for this holder in this stock. | ||||||